$VTGN 🚀 🔹 Topline results expected by the end of June for PALISADE-4 Phase 3 fasedienol study 📈 🔹 Fasedienol targets acute treatment of social anxiety disor

$VTGN 🚀 🔹 Topline results expected by the end of June for PALISADE-4 Phase 3 fasedienol study 📈 🔹 Fasedienol targets acute treatment of social anxiety disorder 🧠 🔹 Company says randomized portion of the trial is complete 🔥 🔹 Positive data could strengthen the case for a potential NDA path 💡…